Ledger.Open graph →
SEC Form D · filed May 26, 2023

RheumaGen, Inc

Offering
$300K
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

James B. Hart, Jr · Denver, COExecGregory L. Andrews · Denver, CODirectorBrian M. Freed · Denver, COExec · DirectorRyan K. Hart · Denver, COExecRichard A. Freed, Iii · Denver, COExec · DirectorMark Bell · Atlanta, GADirectorRodney M. Hamilton · Franklin, TNExec · DirectorChristine Thompson · Atlanta, GAExecPeter Clarke · Vancouver, British Columbia, CanadaExec · DirectorBenton Heinzelmann · Fort Worth, TXExecBrenton Fargnoli · Nashville, TNExecVijay Patel · Nashville, TNExecTcim GP LLC · New York, NYDirectorHollie Haynes · SAN FRANCISCO, CAExec · DirectorGerard J. Frigon · Scottsdale, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗